• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症相关成纤维细胞衍生的外泌体通过 miR-92/PD-L1 通路抑制乳腺癌中免疫细胞的功能。

Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway.

机构信息

Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Department of Information, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Front Immunol. 2020 Oct 9;11:2026. doi: 10.3389/fimmu.2020.02026. eCollection 2020.

DOI:10.3389/fimmu.2020.02026
PMID:33162971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7581790/
Abstract

Cancer-associated fibroblasts (CAFs) are an essential component in the tumor microenvironment and have been reported to contribute to tumor progression through many mechanisms; however, the detailed mechanism underlying the immune-suppression effect of CAFs is not clearly defined. In this study, human breast cancer-derived CAFs were cultured, and CAF-derived exosomes in a culture medium were isolated. Using a miRNA profiles assay, we identify a significantly higher level of microRNA-92 isolated in CAFs exosomes. After treatment by CAF-derived exosomes, breast cancer cells express higher programmed cell death receptor ligand 1 (PD-L1), accompanied with increased miR-92 expression. Increased PD-L1 expression, which was induced by CAF-derived exosomes, significantly promotes apoptosis and impaired proliferation of T cells. The underlying mechanism of this effect was studied, proliferation and migration of breast cancer cells were increased after the transfection of miR-92, LATS2 was recognized as a target gene of miR-92, and further confirmed by a luciferase assay. Immunoprecipitation showed that LATS2 can interact with YAP1, chromatin immunoprecipitation confirmed that after nuclear translocation YAP1 could bind to the enhancer region of PD-L1 to promotes transcription activity. Furthermore, the animal study confirmed that CAFs significantly promoted tumor progression and impaired the function of tumor-infiltrated immune cells . Our data revealed a novel mechanism that can induce immune suppression in the tumor microenvironment.

摘要

癌症相关成纤维细胞(CAFs)是肿瘤微环境的重要组成部分,已被报道通过多种机制促进肿瘤进展;然而,CAFs 免疫抑制作用的详细机制尚不清楚。在这项研究中,培养了人乳腺癌来源的 CAFs,并分离了培养基中的 CAF 衍生的外泌体。通过 miRNA 谱分析,我们鉴定出 CAFs 外泌体中 microRNA-92 的水平显著升高。用 CAF 衍生的外泌体处理后,乳腺癌细胞表达更高水平的程序性死亡受体配体 1(PD-L1),同时伴有 miR-92 表达增加。CAF 衍生的外泌体诱导的 PD-L1 表达增加显著促进 T 细胞凋亡和增殖受损。研究了这种作用的潜在机制,miR-92 的转染增加了乳腺癌细胞的增殖和迁移,LATS2 被认为是 miR-92 的靶基因,并通过荧光素酶测定进一步证实。免疫沉淀显示 LATS2 可以与 YAP1 相互作用,染色质免疫沉淀证实,核转位后 YAP1 可以与 PD-L1 的增强子区域结合,促进转录活性。此外,动物研究证实 CAFs 显著促进肿瘤进展并损害肿瘤浸润免疫细胞的功能。我们的数据揭示了一种新的机制,可以在肿瘤微环境中诱导免疫抑制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/9241040587be/fimmu-11-02026-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/5348b9451eee/fimmu-11-02026-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/ba73db38aa68/fimmu-11-02026-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/94587f17f77d/fimmu-11-02026-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/7f68ddea8434/fimmu-11-02026-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/a76c30979b1c/fimmu-11-02026-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/9241040587be/fimmu-11-02026-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/5348b9451eee/fimmu-11-02026-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/ba73db38aa68/fimmu-11-02026-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/94587f17f77d/fimmu-11-02026-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/7f68ddea8434/fimmu-11-02026-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/a76c30979b1c/fimmu-11-02026-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2525/7581790/9241040587be/fimmu-11-02026-g006.jpg

相似文献

1
Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway.癌症相关成纤维细胞衍生的外泌体通过 miR-92/PD-L1 通路抑制乳腺癌中免疫细胞的功能。
Front Immunol. 2020 Oct 9;11:2026. doi: 10.3389/fimmu.2020.02026. eCollection 2020.
2
Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1/ miR-142-5p/ PD-L1 axis.癌相关成纤维细胞衍生的外泌体通过 OIP5-AS1/miR-142-5p/PD-L1 轴促进肺癌进展。
Mol Immunol. 2021 Dec;140:47-58. doi: 10.1016/j.molimm.2021.10.002. Epub 2021 Oct 13.
3
Cancer-associated fibroblasts-derived exosomal ZNF250 promotes the proliferation, migration, invasion, and immune escape of hepatocellular carcinoma cells by transcriptionally activating PD-L1.癌相关成纤维细胞来源的外泌体 ZNF250 通过转录激活 PD-L1 促进肝癌细胞的增殖、迁移、侵袭和免疫逃避。
J Biochem Mol Toxicol. 2024 Sep;38(9):e23778. doi: 10.1002/jbt.23778.
4
MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.miR-92 通过 LATS2/YAP1/PD-L1 通路过表达抑制卵巢癌细胞免疫功能。
Clin Transl Oncol. 2021 Mar;23(3):450-458. doi: 10.1007/s12094-020-02439-y. Epub 2020 Jul 11.
5
Exosomal circHIF1A derived from hypoxic-induced carcinoma-associated fibroblasts promotes hepatocellular carcinoma cell malignant phenotypes and immune escape.外泌体 circHIF1A 来源于缺氧诱导的癌相关成纤维细胞,促进肝癌细胞的恶性表型和免疫逃逸。
Int Immunopharmacol. 2024 Sep 10;138:112282. doi: 10.1016/j.intimp.2024.112282. Epub 2024 Jun 26.
6
Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.源自癌症相关成纤维细胞的外泌体miR-500a-5p通过靶向USP28促进乳腺癌细胞增殖和转移。
Theranostics. 2021 Feb 6;11(8):3932-3947. doi: 10.7150/thno.53412. eCollection 2021.
7
Exosomal miRNA-92a derived from cancer-associated fibroblasts promote invasion and metastasis in breast cancer by regulating G3BP2.外泌体 miR-92a 来源于癌症相关成纤维细胞,通过调控 G3BP2 促进乳腺癌的侵袭和转移。
Cell Signal. 2024 Jul;119:111182. doi: 10.1016/j.cellsig.2024.111182. Epub 2024 Apr 17.
8
Cancer-associated fibroblasts contribute to oral cancer cells proliferation and metastasis via exosome-mediated paracrine miR-34a-5p.癌相关成纤维细胞通过外泌体介导的旁分泌 miR-34a-5p 促进口腔癌细胞的增殖和转移。
EBioMedicine. 2018 Oct;36:209-220. doi: 10.1016/j.ebiom.2018.09.006. Epub 2018 Sep 20.
9
Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.乳腺癌来源的外泌体通过 miR-146a 调节乳腺癌中的细胞侵袭和转移,从而激活肿瘤微环境中的癌相关成纤维细胞。
Exp Cell Res. 2020 Jun 15;391(2):111983. doi: 10.1016/j.yexcr.2020.111983. Epub 2020 Apr 5.
10
Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.肿瘤相关成纤维细胞来源的外泌体 miR-320a 的丢失促进 HCC 的增殖和转移。
Cancer Lett. 2017 Jul 1;397:33-42. doi: 10.1016/j.canlet.2017.03.004. Epub 2017 Mar 10.

引用本文的文献

1
Role of extracellular vesicles in cancer: implications in immunotherapeutic resistance.细胞外囊泡在癌症中的作用:对免疫治疗耐药性的影响
Front Immunol. 2025 May 22;16:1581635. doi: 10.3389/fimmu.2025.1581635. eCollection 2025.
2
Emerging roles of non-coding RNA derived from extracellular vesicles in regulating PD-1/PD-L1 pathway: insights into cancer immunotherapy and clinical applications.源自细胞外囊泡的非编码RNA在调节PD-1/PD-L1通路中的新作用:对癌症免疫治疗和临床应用的见解
Cancer Cell Int. 2025 May 23;25(1):188. doi: 10.1186/s12935-025-03809-8.
3
Editorial Expression of Concern: A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.

本文引用的文献

1
Crosstalk between cancer-associated fibroblasts and immune cells in cancer.肿瘤相关成纤维细胞与肿瘤免疫细胞间的串扰。
J Cell Mol Med. 2020 Jan;24(1):13-24. doi: 10.1111/jcmm.14745. Epub 2019 Oct 23.
2
Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer.癌相关成纤维细胞增强结直肠癌中肿瘤相关巨噬细胞的富集并抑制 NK 细胞的功能。
Cell Death Dis. 2019 Mar 20;10(4):273. doi: 10.1038/s41419-019-1435-2.
3
Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer.
关注编辑声明:一种新型4-氨基喹唑啉衍生物DHW-208通过靶向PI3K/AKT/mTOR途径抑制人乳腺癌细胞的生长。
Cell Death Dis. 2025 Mar 27;16(1):216. doi: 10.1038/s41419-025-07539-7.
4
Tumor cell-derived EMP1 is essential for cancer-associated fibroblast infiltration in tumor microenvironment of triple-negative breast cancer.肿瘤细胞衍生的EMP1对于三阴性乳腺癌肿瘤微环境中癌症相关成纤维细胞的浸润至关重要。
Cell Death Dis. 2025 Feb 27;16(1):143. doi: 10.1038/s41419-025-07464-9.
5
Exosomes: a double-edged sword in cancer immunotherapy.外泌体:癌症免疫治疗中的双刃剑。
MedComm (2020). 2025 Feb 17;6(3):e70095. doi: 10.1002/mco2.70095. eCollection 2025 Mar.
6
Extracellular vesicles in tumor immunity: mechanisms and novel insights.肿瘤免疫中的细胞外囊泡:机制与新见解
Mol Cancer. 2025 Feb 14;24(1):45. doi: 10.1186/s12943-025-02233-w.
7
Exosome-mediated Crosstalk in the Tumor Immune Microenvironment: Critical Drivers of Hepatocellular Carcinoma Progression.外泌体介导的肿瘤免疫微环境中的细胞间通讯:肝细胞癌进展的关键驱动因素
J Clin Transl Hepatol. 2025 Feb 28;13(2):143-161. doi: 10.14218/JCTH.2024.00302. Epub 2024 Nov 28.
8
Cancer-associated fibroblast-secreted exosomal miR-454-3p inhibits lipid metabolism and ferroptosis in breast cancer by targeting ACSL4.癌症相关成纤维细胞分泌的外泌体miR-454-3p通过靶向ACSL4抑制乳腺癌中的脂质代谢和铁死亡。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3925-3937. doi: 10.1007/s00210-024-03488-8. Epub 2024 Oct 7.
9
Noncoding Ribonucleic Acids (RNAs) May Improve Response to Immunotherapy in Pancreatic Cancer.非编码核糖核酸(RNAs)可能改善胰腺癌对免疫疗法的反应。
ACS Pharmacol Transl Sci. 2024 Aug 7;7(9):2557-2572. doi: 10.1021/acsptsci.3c00394. eCollection 2024 Sep 13.
10
CAF-induced physical constraints controlling T cell state and localization in solid tumours.CAF 诱导的物理约束控制实体瘤中 T 细胞的状态和定位。
Nat Rev Cancer. 2024 Oct;24(10):676-693. doi: 10.1038/s41568-024-00740-4. Epub 2024 Sep 9.
青蒿素衍生物通过抑制 TGF-β 信号通路在乳腺癌中失活肿瘤相关成纤维细胞。
J Exp Clin Cancer Res. 2018 Nov 26;37(1):282. doi: 10.1186/s13046-018-0960-7.
4
Cancer-associated fibroblasts as key regulators of the breast cancer tumor microenvironment.癌症相关成纤维细胞作为乳腺癌肿瘤微环境的关键调节者。
Cancer Metastasis Rev. 2018 Dec;37(4):577-597. doi: 10.1007/s10555-018-9768-3.
5
Anti-PD-1 and PD-L1 antibodies in metastatic melanoma.转移性黑色素瘤中的抗程序性死亡蛋白1(PD-1)和程序性死亡配体1(PD-L1)抗体
Melanoma Manag. 2017 Dec;4(4):175-178. doi: 10.2217/mmt-2017-0018. Epub 2017 Nov 21.
6
Overcoming Acquired PD-1/PD-L1 Resistance with CD38 Blockade.通过阻断CD38克服获得性PD-1/PD-L1耐药性。
Cancer Discov. 2018 Sep;8(9):1066-1068. doi: 10.1158/2159-8290.CD-18-0798.
7
Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis.癌相关成纤维细胞影响乳腺癌细胞的基因表达、侵袭和血管生成。
Cell Oncol (Dordr). 2018 Aug;41(4):369-378. doi: 10.1007/s13402-018-0371-y. Epub 2018 Mar 1.
8
PD-L1 confers resistance to EGFR mutation-independent tyrosine kinase inhibitors in non-small cell lung cancer via upregulation of YAP1 expression.程序性死亡配体1(PD-L1)通过上调Yes相关蛋白1(YAP1)的表达,赋予非小细胞肺癌对表皮生长因子受体(EGFR)突变非依赖性酪氨酸激酶抑制剂的耐药性。
Oncotarget. 2017 Dec 8;9(4):4637-4646. doi: 10.18632/oncotarget.23161. eCollection 2018 Jan 12.
9
YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma.YAP 诱导的 PD-L1 表达驱动 BRAFi 耐药黑色素瘤中的免疫逃逸。
Cancer Immunol Res. 2018 Mar;6(3):255-266. doi: 10.1158/2326-6066.CIR-17-0320. Epub 2018 Jan 30.
10
Chemotherapy induces enrichment of CD47/CD73/PDL1 immune evasive triple-negative breast cancer cells.化疗诱导 CD47/CD73/PDL1 免疫逃避性三阴性乳腺癌细胞富集。
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1239-E1248. doi: 10.1073/pnas.1718197115. Epub 2018 Jan 24.